Syros Pharmaceuticals Ownership | Who Owns Syros Pharmaceuticals?
Syros Pharmaceuticals Ownership Summary
100.00% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.44% of its assets in Syros Pharmaceuticals shares.
SYRS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Syros Pharmaceuticals | - | - | 100.00% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2023 | 1 | - | 219 | - | - | 125000.00% | - | - | - | - |
| Dec 31, 2022 | 1 | -66.67% | 219 | -99.98% | - | 0.01% | - | -100.00% | - | -100.00% |
| Sep 30, 2022 | 3 | -95.16% | 881,719 | -97.52% | 3 | 1.94% | 1 | -96.30% | 1 | -95.65% |
| Jun 30, 2022 | 62 | -31.87% | 35,569,373 | -20.26% | 12 | 4.98% | 27 | -32.50% | 23 | -25.81% |
| Mar 31, 2022 | 91 | 1.11% | 44,604,457 | -12.84% | 16 | 4.74% | 40 | -4.76% | 31 | -3.13% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 654.18K | 2.44% | - |
| Kennedy Micro Cap | 328.08K | 1.22% | 1.64K |
| Vanguard Institutional Extnd Mkt Idx Tr | 257.63K | 0.96% | - |
| Fidelity Extended Market Index | 102.37K | 0.38% | -24.20K |
| iShares Micro-Cap ETF | 56.60K | 0.21% | - |
| Bridgeway Ultra-Small Company Market | 50.67K | 0.19% | - |
| Kennedy Micro Cap Opportunities | 47.18K | 0.18% | 170.00 |
| BlackRock Extended Equity Market K | 45.36K | 0.17% | -19.00 |
| Fidelity Total Market Index | 39.96K | 0.15% | - |
| Fidelity Series Total Market Index | 23.73K | 0.09% | -5.77K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 02, 2024 | Simonian Nancy A | - | Sell | $10.02K |
| Nov 25, 2024 | Simonian Nancy A | - | Sell | $35.74K |
| Nov 18, 2024 | Stephens Kristin | Chief Development Officer | Sell | $7.95K |
| Nov 18, 2024 | Roth David | Chief Medical Officer | Sell | $2.38K |
| Nov 19, 2024 | Quirk Gerald E | Chief Legal & Compliance Offic | Sell | $10.32K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 7 |
| 2024 Q3 | 5 | - |
| 2024 Q2 | - | 3 |
| 2024 Q1 | - | - |
| 2023 Q4 | 1 | 2 |
SYRS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools